Hamburg, Hamburg, Germany
Chief Executive Officer with more than 24 years of international leadership experience across MedTech, healthcare technology and life sciences. Passionate about building high-performing organizations that deliver sustainable growth through customer focus, operational excellence and disciplined execution. Throughout my career I have led global commercial organizations, business transformations and market expansion initiatives across Europe, North America, China, Japan and APAC, consistently combining strategic vision with hands-on execution. At VirtaMed, my focus is on profitable growth, strengthening customer partnerships and advancing simulation-based medical education to improve healthcare outcomes worldwide. Key skills, responsibilities, experiences: - 24+ years Start-Up experience - International business experience in Europe, Middle East, Japan, China, South East Asia, South Korea, Australia and North America - Definition, execution and monitoring of strategic business plans in the territories - P&L responsibility - Distributor management and contract negotiation - Corporate OEM partner management and contract negotiation, Siemens, Philips, GE - External consultants management and contract negotiation - Capital equipment sales - Disposables sales - Building and leading high-performance teams - Experience in minimally and non-invasive image guided therapies in neurosurgery, urology, women's health, oncology, pediatrics - MRI imaging, radiology experience with Siemens, Philips, GE high-field systems - Therapeutic ultrasound experience for non-invasive therapies - Global Key Opinion Leader KOL identification and customer relationship building and management - Healthcare Reimbursement, regulatory & Go-to-Market strategies for public and private healthcare sector - DTP, DTC campaigns, direct to patients, direct to customer (B2B) management - M&A merger and acquisition of new technology incl. implementation and integration into the organisation - Scale-up experience - Expatriate experience being two years based in Singapore managing the APAC territory - Contract negotiations with distributors and OEM partners - Cross functional and global team building and management, cultural awareness - Analytical skills - Business Development
As Chief Executive Officer of VirtaMed AG, I am responsible for leading the company's global strategy, business performance and organizational development. Together with our leadership team, we are focused on building a scalable, customer-centric MedTech company that delivers sustainable growth while advancing simulation-based medical education and surgical training worldwide. My responsibilities include: • Defining and executing the company's global strategy • Leading worldwide commercial, operational and financial performance • Driving profitable growth, cash generation and long-term shareholder value • Building a high-performance organization focused on execution excellence • Strengthening strategic partnerships with healthcare providers, medical societies and MedTech industry leaders • Overseeing Product Management, Engineering, Operations, Finance, Marketing and Global Commercial functions • Advancing VirtaMed's portfolio of high-fidelity medical simulation solutions across hospital and industry markets VirtaMed develops high-fidelity medical simulators that enable healthcare professionals to acquire, refine and assess procedural skills in a safe, evidence- and proficiency-based learning environment. Our solutions support hospitals, universities, medical societies and leading medical device companies around the world in improving clinical training and patient outcomes.
Responsible for the rest of world (EMEA, China, APAC, Japan, India) commercial strategy and execution of VirtaMed's medical simulation and surgical training portfolio. Key responsibilities: • Lead RoW (outside the Americas)) Sales, Marketing, Business Development, Customer Success, and Commercial Operations • Define and execute go-to-market and revenue growth strategies • Drive market expansion across healthcare systems, universities, private institutions and professional societies • Establish and manage strategic partnership collaborations • Improve forecasting, pipeline management, and commercial performance • Support corporate strategy and portfolio development Focus areas: Medical Simulation | Surgical Education | Healthcare Technology | Commercial Strategy | Revenue Growth | EMEA; China, APAC Sales | Business Development | Strategic Partnerships | Go-to-Market Strategy | Customer Success | Corporate Strategy | Proficiency-based Education I Direct Sales I Channel Sales
Key Objectives: Continuation of the development and execution of the commercialization and adoption strategies of TULSA-PRO in various countries across Europe, Middle East and Asia incl. but not limited to potential assessment, regulatory, reimbursement, KOL development, societies, advocacy groups, OEM and distribution partners, marketing campaigns Key Achievements: Further installations in South East Asia, Japan, China, and Netherlands Driving measurable awareness and pipeline growth across SEA and EMEA by adding key commercial resources locally and utilizing US KOL's to present at regional conferences Establishing agent and distributor networks in Italy and Spain and India Negotiation and closing of Co-Sales & Co-Marketing Agreement with Siemens Healthineers for the joint commercialization of the combined solution of Siemens Magnetom Free.Max and TULSA-PRO Clinical Applications: Urology (prostate cancer, BPH, RT salvage), womens health (uterine fibroids, adenomyosis), bone metastasis, desmoid tumors, osteoid osteoma, research indications, radiology, interventional radiology Coverage: Europe, Middle East, China, India, Japan, South Korea, South East Asia, Australia/New Zealand
Key Objectives: Joining Profound Medical before CE and FDA approvals as first employee the objective was to build the entire infrastructure in EMEA followed by APAC as well as the KOL (urology, radiology) network in perparation for the commercial launch post regulatory approval (market access strategies, reimbursement, marketing, sales, service, clinical application) Key Achievements: Growing revenues from 0 to 6M$ (2019) First installations in Barcelona, Spain, Univ. Cologne, Univ. Aachen and Univ. Heidelberg, Germany, Univ. Radboud UMC, Netherlands, UCLH, London, Univ. Turku, Finland as well as in France, China and Japan Active involvement of Sonalleve MR-HIFU business unit acquisition from Philips Netherlands including post acquisition implementation in 2017 Establishing agent and distributor networks in South East Asia, Japan and initiating negotiations in Italy and Spain Implementing TULSA-PRO in OEM partner sales catalogues (Siemens, Philips) for defined territories Clinical Applications: Urology (prostate cancer, BPH, RT salvage), womens health (uterine fibroids, adenomyosis), bone metastasis, desmoid tumors, osteoid osteoma, research indications, radiology, interventional radiology Coverage: Europe, Middle East, China, Japan, Korea, South East Asia, Australia/New Zealand
Key Objectives: Driving the commercial (sales, marketing, BD, project management, installation, service & support, KOL management) growth for IMRIS (neurosurgery & neurovascular, interventional radiology, cardiology) for the entire oUS markets with focus on EMEA and APAC. Building and maintaining close collaboration with global Siemens organization to drive joint sales and marketing initiatives Key Achievements: Driving annual revenues to +35M$ First sales and installations in Saudi Arabia and Sweden at a total of 12M$ Managing a team of 15 direct reports plus the entire distributor and agent network KOL development and management in close collaboration with US based KOL's Coverage: EMEA, India, Japan, Korea, South East Asia, Australia/New Zealand
Key Objectives: Building the business for IMRIS (neurosurgery & neurovascular, interventional radiology, cardiology) in APAC from being the first employee in Singapore towards a full commercial operations (sales, marketing, BD, project management, installation, service & support, KOL management) across the APAC markets. Managing Director for IMRIS Singapore Pte. Ltd. as well as IMRIS KK. Japan. Building and maintaining close collaboration with global Siemens organization to drive joint sales and marketing initiatives Key Achievements: Driving revenue growth from 0 to +15$ annually in the region Setup of an agent and distributor network across South East Asia, Australia, India and Japan with a direct team of +5 employees Setup legal entity in Singapore and in Japan as managing director Coverage: India, Japan, Korea, South East Asia, Australia/New Zealand
Key Objectives: Building the business for IMRIS (neurosurgery & neurovascular, interventional radiology, cardiology) from being the first employee in Europe towards a full commercial operations (sales, marketing, BD, project management, installation, service & support) across the EMEA markets. Managing Director for IMRIS Germany GmbH. Building and maintaining close collaboration with global Siemens organization to drive joint sales and marketing initiatives Key Achievements: Driving revenue growth from 0 to +30M$ annually First system sales in Germany (4M$), Middle East (12M$), France (7M$) Setup of legal entity in Germany as managing director and growing a commercial team of 15 employees Setup of an agent and distributor network across EMEA Coverage: EMEA
Key Objectives: Driving the global intra-operative solutions (neurosurgery, orthopedic, interventional radiology) commercial growth by building regional commercial teams in the US, EMEA and APAC. Liaise with OEM partner Siemens on corporate and local country levels to drive joint sales efforts Key Achievements: Annual revenue responsibility of +30M$ Building and managing a global commercial team of +40 employees Program implementations at leading US hospitals: Univ. of Dallas, TX, Memorial Sloan Kettering, NY, MD Anderson Cancer Center Houston, TX, UCLA Los Angeles, CA Coverage: US, EMEA, India, Japan, Korea, South East Asia, Australia/New Zealand
Key Objectives: Driving the global intra-operative solutions (neurosurgery, orthopedic, interventional radiology) growth by building regional technical consulting teams in the US, EMEA and APAC. Liaise with OEM partner Siemens on corporate and local country levels to drive joint sales efforts Key Achievements: Global first implementations of fully-integrated operating theaters in US (Staten Island, NY), EU (Rome, Italy), Asia (Nagoya, Japan and at SGH in Singapore) Capital equipment at +4M$ per system Coverage: US, EMEA, India, Japan, Korea, South East Asia, Australia/New Zealand